EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Trends in the Incidence of Rare Eyelid Malignancies: A Surveillance, Epidemiology, and End Results-Based Study (2000–2021)

Said Yaseen, Shaimaa Abdelaziz Abdelmoneim, Ahmed Sermed Al Sakini, Bashar I Almaraziq, Joud Khaled Alhousani, Mohamed Ahmed Ali, Leen Abu Rabi, Shahd Mustafa Alsharif, Sari AlMousa, Hashem Abu Serhan

Ocular Oncology and Pathology · 11.12.2025 · 12 (1) · 1-17

DOI: 10.1159/000549967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 11.12.2025. Verfasst von Said Yaseen und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Jordan University of Science and Technology, Irbid, Jordan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Malignant eyelid tumors, despite being rare, are on the rise, especially in the older population, with risk factors including ultraviolet light exposure. Trends have been notable to be different among different genders, races, age groups, etc. Therefore, analyzing temporal trends in the incidence of eyelid cancers, including malignant melanoma (MM), Merkel cell carcinoma (MCC), and sebaceous gland carcinoma (SGC), and predicting future patterns would definitely improve our understanding of the disease.

Methods

A retrospective study was conducted on the Surveillance, Epidemiology, and End Results (SEER) database spanning 2000–2021. Time series models were applied to estimate incidence rates (IRs) per 100,000. The best models were selected based on root mean square error (RMSE) and Akaike information criterion. Poisson regression was used to assess the impact of gender and age ≥60 on IRs.

Results

The autoregressive integrated moving average (ARIMA)(0,1,0) model (RMSE = 0.0144, Akaike information criterion = −100.23) showed an increasing overall trend in eyelid cancers IRs from 2000 to 2015, declining slightly until 2020 (IR = 0.1028), then rising again in 2021. The 10-year forecast predicts an increase to 0.13 (95% PI: 0.11–0.15). For MM, error, trend, seasonal (M,N,N) model indicated a gradual IR rise until 2010, followed by a decline, and subsequent rise to 0.068 in 2020; predicted to reach 0.081 (95% PI: 0.062–0.100) by 2022. For MCC, neural network autoregression (2,2) model showed IR stability (0.003–0.008), with a slight drop in 2021 (IR = 0.006), and predicted to decrease to 0.01 (95% PI: 0–0.01). For SGC, ARIMA(0,0,0) model demonstrated a decline in IR in 2011 (IR = 0.0192), increase until 2019, then decrease in 2021 (IR = 0.0246), with a predicted 10-year decrease to 0.026 (95% PI: 0.019–0.032). Poisson regression revealed that age ≥60 significantly increased IRR for both MM and SGC (17.0 and 25.4, respectively). Gender was nonsignificant for all three cancers.

Conclusion

Incidence of eyelid cancers revealed variable temporal trends, with a slight overall increase projected. Age ≥60 is a strong risk factor, particularly for MM and SGC.

Schlagwörter

Stichwörter der Autor:innen

Eyelid malignanciesMalignant melanomaMerkel cell carcinomaSebaceous adenocarcinomaSurveillance, Epidemiology, and End Results database

Autor:innen und Institutionen

  • School of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
  • Clinical Research Administration, Directorate of Health Affairs, Egyptian Ministry of Health and Population, Alexandria, Egypt.
  • Faculty of Medicine, University of Baghdad, Baghdad, Iraq.
  • School of Medicine, Hashemite University, Zarqa, Jordan.
  • Qena Faculty of Medicine, South Valley University, Qena, Egypt.
  • Medical Research Group of Egypt, Negida Academy, Arlington, MA, USA.

Zitieren

APA

Yaseen, S., Abdelmoneim, S. A., Al Sakini, A. S., Almaraziq, B. I., Alhousani, J. K., Ali, M. A., Abu Rabi, L., Alsharif, S. M., AlMousa, S., & Abu Serhan, H. (2025). Trends in the Incidence of Rare Eyelid Malignancies: A Surveillance, Epidemiology, and End Results-Based Study (2000–2021). Ocular Oncology and Pathology, 12(1), 1-17. https://doi.org/10.1159/000549967

Vancouver

Yaseen S, Abdelmoneim SA, Al Sakini AS, Almaraziq BI, Alhousani JK, Ali MA, et al. Trends in the Incidence of Rare Eyelid Malignancies: A Surveillance, Epidemiology, and End Results-Based Study (2000–2021). Ocular Oncology and Pathology. 2025;12(1):1-17. doi:10.1159/000549967

BibTeX
@article{Yaseen2025,
  author = {Yaseen, Said and Abdelmoneim, Shaimaa Abdelaziz and Al Sakini, Ahmed Sermed and Almaraziq, Bashar I and Alhousani, Joud Khaled and Ali, Mohamed Ahmed and Abu Rabi, Leen and Alsharif, Shahd Mustafa and AlMousa, Sari and Abu Serhan, Hashem},
  title = {Trends in the Incidence of Rare Eyelid Malignancies: A Surveillance, Epidemiology, and End Results-Based Study (2000–2021)},
  journal = {Ocular Oncology and Pathology},
  year = {2025},
  volume = {12},
  number = {1},
  pages = {1--17},
  doi = {10.1159/000549967}
}
Kostenlos starten →